Abstract
Mucous epithelia and their glands represent vital surfaces of the body which are topologically in direct contact and communicate with the environment. These highly specialized epithelia are protected by several lines of defence, such as mucous gels, regeneration and repair mechanisms, and acute inflammatory processes. Pathologically, chronic inflammation is associated with cancer. There are two different regeneration and repair mechanisms of mucous epithelia known which also cover different time scales. First, rapid repair of superficial lesions via cell migration - a process called restitution - starts within minutes. Second, continuous regeneration via differentiation and proliferation of stem and progenitor cells is responsible for self-renewal within days to months. This article reviews molecular mechanisms responsible for the regeneration of various mucous epithelia with a special emphasis on the complex situation in the gastric mucosa and its glands. For example, the two gross types of gastric units, i.e., the fundic and the antral types, respectively, differ largely by their histology, regeneration rates and regeneration profiles. Currently, a rough picture is emerging on the molecular mechanisms behind including the characterization of different somatic stem cell types and stem cell signaling pathways. Furthermore, dysregulated regeneration is well known now as a cause of various metaplasias (reversible remodeling of epithelia) and cancer, with chronic inflammation playing a key role. Understanding the molecular mechanisms of regeneration and their dysregulation is essential for the development of new strategies for cancer prevention and therapy and it will also promote the emerging field of regenerative medicine and tissue engineering.
Keywords: Gastric mucosa, regenerative medicine, stem cells, regeneration, gastric cancer, intestinal metaplasia, SPEM, trefoil factors
Current Medicinal Chemistry
Title: Regeneration of the Gastric Mucosa and its Glands from Stem Cells
Volume: 15 Issue: 29
Author(s): Werner Hoffmann
Affiliation:
Keywords: Gastric mucosa, regenerative medicine, stem cells, regeneration, gastric cancer, intestinal metaplasia, SPEM, trefoil factors
Abstract: Mucous epithelia and their glands represent vital surfaces of the body which are topologically in direct contact and communicate with the environment. These highly specialized epithelia are protected by several lines of defence, such as mucous gels, regeneration and repair mechanisms, and acute inflammatory processes. Pathologically, chronic inflammation is associated with cancer. There are two different regeneration and repair mechanisms of mucous epithelia known which also cover different time scales. First, rapid repair of superficial lesions via cell migration - a process called restitution - starts within minutes. Second, continuous regeneration via differentiation and proliferation of stem and progenitor cells is responsible for self-renewal within days to months. This article reviews molecular mechanisms responsible for the regeneration of various mucous epithelia with a special emphasis on the complex situation in the gastric mucosa and its glands. For example, the two gross types of gastric units, i.e., the fundic and the antral types, respectively, differ largely by their histology, regeneration rates and regeneration profiles. Currently, a rough picture is emerging on the molecular mechanisms behind including the characterization of different somatic stem cell types and stem cell signaling pathways. Furthermore, dysregulated regeneration is well known now as a cause of various metaplasias (reversible remodeling of epithelia) and cancer, with chronic inflammation playing a key role. Understanding the molecular mechanisms of regeneration and their dysregulation is essential for the development of new strategies for cancer prevention and therapy and it will also promote the emerging field of regenerative medicine and tissue engineering.
Export Options
About this article
Cite this article as:
Hoffmann Werner, Regeneration of the Gastric Mucosa and its Glands from Stem Cells, Current Medicinal Chemistry 2008; 15 (29) . https://dx.doi.org/10.2174/092986708786848587
DOI https://dx.doi.org/10.2174/092986708786848587 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Topoisomerase I and II Inhibitors: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation
Anti-Cancer Agents in Medicinal Chemistry Genetic Manipulation of Human Embryonic Stem Cells: A System to Study Early Human Development and Potential Therapeutic Applications
Current Gene Therapy Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments
Current Pharmaceutical Design Natural Bio-Drugs as Matrix Metalloproteinase Inhibitors: New Perspectives on the Horizon?
Recent Patents on Anti-Cancer Drug Discovery Cell Proliferation and Cytotoxicity Assays
Current Pharmaceutical Biotechnology Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry - Central Nervous System Agents NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications
Current Medicinal Chemistry Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)
Current Cancer Drug Targets Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues
Recent Patents on Anti-Cancer Drug Discovery Other Potential Therapeutic Targets in Thyroid Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives
Current Medicinal Chemistry RNA Interference: A New Targeted Tumour Therapy?
Current Cancer Therapy Reviews Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design Immune Checkpoint Inhibitors in AML-A New Frontier
Current Cancer Drug Targets